by Tanya Ridding
Posted in MedTech & Devices
Over the past few years, we’ve seen a noticeable shift in how venture capitalists operate - behaving more like private equity (PE) in their reduced appetite for risk, increasing demands for operational exits, expanded timelines and a mindset of proven profitability > potential. What do these challenges mean for Medtech founders and CEOs?